In case anyone needed more evidence supporting Max's statement this sobering comment from the Optician about gene therapy for ocular diseases may be of interest. The article says:
So here we have diseases of the eye, generally regarded as the easiest target for gene therapy, taking two decades to report results. Kinda makes a few weeks delay for TT-034 seem insignificant don't you think?
- Forums
- ASX - By Stock
- BLT
- time for a reality check
time for a reality check, page-5
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online